Research graph
References from Targeting non-structural proteins of Hepatitis C virus for predicting repurposed drugs using QSAR and machine learning approaches. Local targets link to admitted publications; unresolved targets remain external evidence.
10.4254/wjh.v7.i10.1377
10.4254/wjh.v7.i10.1377 · External reference
10.1016/s0140-6736(14)62401-6
10.1016/s0140-6736(14)62401-6 · External reference
Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections
10.1007/s00705-022-05375-0 · 2022 · External reference
Delayed by Design: Role of Suboptimal Signal Peptidase Processing of Viral Structural Protein Precursors in Flaviviridae Virus Assembly
10.3390/v12101090 · 2020 · External reference
10.3390/v7122968
10.3390/v7122968 · External reference
10.1016/j.jhep.2011.01.011
10.1016/j.jhep.2011.01.011 · External reference
Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants
2019 · External reference
Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection
10.1016/j.jhep.2018.07.002 · 2018 · External reference
Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus
10.1002/hep.24262 · 2011 · External reference
10.1021/acs.jpca.5b12286
10.1021/acs.jpca.5b12286 · External reference
Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection
2015 · External reference
10.1002/hep.28111
10.1002/hep.28111 · External reference
AVCpred: an integrated web server for prediction and design of antiviral compounds
10.1111/cbdd.12834 · 2017 · External reference
AVPpred: collection and prediction of highly effective antiviral peptides
10.1093/nar/gks450 · 2012 · External reference
HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors
10.1186/s13321-018-0266-y · 2018 · External reference
Anti-flavi: A Web Platform to Predict Inhibitors of Flaviviruses Using QSAR and Peptidomimetic Approaches
2018 · External reference
Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning
2021 · External reference
10.1002/jcc.26223
10.1002/jcc.26223 · External reference
QSAR and docking studies of HCV NS3 serine protease inhibitors
10.2174/1573406411309060003 · 2013 · External reference
10.1002/jcb.26262
10.1002/jcb.26262 · External reference
10.1007/s10822-021-00418-1
10.1007/s10822-021-00418-1 · External reference
10.1093/nar/gkr777
10.1093/nar/gkr777 · External reference
10.1186/1758-2946-3-33
10.1186/1758-2946-3-33 · External reference
10.1002/jcc.21707
10.1002/jcc.21707 · External reference
A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information
10.1016/j.jchromb.2012.05.020 · 2012 · External reference
Recursive feature elimination for brain tumor classification using desorption electrospray ionization mass spectrometry imaging
2012 · External reference
Prediction and Risk Assessment Models for Subarachnoid Hemorrhage: A Systematic Review on Case Studies
10.1155/2022/5416726 · 2022 · External reference
Applicability Domain: A Step Toward Confident Predictions and Decidability for QSAR Modeling
10.1007/978-1-4939-7899-1_6 · 2018 · External reference
DecoyFinder: an easy-to-use python GUI application for building target-specific decoy sets
10.1093/bioinformatics/bts249 · 2012 · External reference
10.1021/acs.jcim.0c00675
10.1021/acs.jcim.0c00675 · External reference
10.1093/nar/gkr320
10.1093/nar/gkr320 · External reference
10.1093/nar/gkx1037
10.1093/nar/gkx1037 · External reference
10.1002/jcc.21256
10.1002/jcc.21256 · External reference
10.1002/jcc.21334
10.1002/jcc.21334 · External reference
Epidemiology of viral hepatitis and hepatocellular carcinoma
10.1053/j.gastro.2011.12.061 · 2012 · External reference
Progress in evaluating the status of hepatitis C infection based on the functional changes of hepatic stellate cells (Review)
2020 · External reference
10.1016/s0168-8278(99)80369-9
10.1016/s0168-8278(99)80369-9 · External reference
Course and outcome of hepatitis C
10.1002/hep.1840360704 · 2002 · External reference
10.1128/jvi.65.3.1105-1113.1991
10.1128/jvi.65.3.1105-1113.1991 · External reference
10.1016/j.virusres.2007.02.001
10.1016/j.virusres.2007.02.001 · External reference
10.1002/hep.21623
10.1002/hep.21623 · External reference
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
10.1056/nejmoa020047 · 2002 · External reference
10.1053/j.gastro.2014.03.003
10.1053/j.gastro.2014.03.003 · External reference
10.1016/j.compbiomed.2021.104677
10.1016/j.compbiomed.2021.104677 · External reference
Unresolved reference
2022 · External reference
Classification models of HCV NS3 protease inhibitors based on support vector machine (SVM)
10.2174/1386207317666141120122554 · 2015 · External reference
QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM)
2017 · External reference
The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors
2021 · External reference
In silico identification and evaluation of leads for the simultaneous inhibition of protease and helicase activities of HCV NS3/4A protease using complex based pharmacophore mapping and virtual screening
10.1371/journal.pone.0089109 · 2014 · External reference
Quantitative structure and bioactivity relationship study on HCV NS5B polymerase inhibitors
10.1080/1062936x.2013.820790 · 2014 · External reference
Combined 3D-QSAR, molecular docking and molecular dynamics study on the benzimidazole inhibitors targeting HCV NS5B polymerase
2020 · External reference
Erythema multiforme during cytomegalovirus infection and oral therapy with terbinafine: a virus-drug interaction
10.1111/j.1468-3083.2004.00806.x · 2004 · External reference
Multiple Fixed Drug Eruption Mimicking Parapsoriasis en Plaque in a Patient with Hepatitis C Virus Infection
2020 · External reference
A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203
10.1532/ijh97.05084 · 2006 · External reference
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling
10.1159/000518297 · 2021 · External reference
Inhibitor Development against p7 Channel in Hepatitis C
2021 · External reference
Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice
10.1016/j.jcmgh.2018.08.008 · 2019 · External reference
Unresolved reference
2021 · External reference
10.1099/jgv.0.000431
10.1099/jgv.0.000431 · External reference
10.1073/pnas.2005463117
10.1073/pnas.2005463117 · External reference
Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells
10.1093/jac/dkm307 · 2007 · External reference
10.1016/j.chom.2016.07.004
10.1016/j.chom.2016.07.004 · External reference
10.1016/j.antiviral.2019.104643
10.1016/j.antiviral.2019.104643 · External reference
10.1074/jbc.m116.716100
10.1074/jbc.m116.716100 · External reference
Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection
10.1016/j.antiviral.2020.104808 · 2020 · External reference
Micafungin Inhibits Dengue Virus Infection through the Disruption of Virus Binding, Entry, and Stability
2021 · External reference
10.1016/j.antiviral.2021.105188
10.1016/j.antiviral.2021.105188 · External reference
Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction
10.3389/fgene.2022.866474 · 2022 · External reference
10.1128/aac.01614-08
10.1128/aac.01614-08 · External reference
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
10.3390/v14020374 · 2022 · External reference
Evaluating Andrographolide as a Potent Inhibitor of NS3-4A Protease and Its Drug-Resistant Mutants Using In Silico Approaches
10.1155/2015/972067 · 2015 · External reference
Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from Terminalia chebula: A Structural
2022 · External reference
Conformational study on telaprevir by HPLC-DAD-MS and theoretical calculation
2019 · External reference
A Refined Model of the HCV NS5A protein bound to daclatasvir explains drug-resistant mutations and activity against divergent genotypes
10.1021/ci400631n · 2015 · External reference
Molecular Docking and Pharmacoinformatics Studies Reveal Potential Phytochemicals Against HCV NS5B Polymerase
10.2174/1386207323666201228160224 · 2022 · External reference
